4//SEC Filing
Toernsen Monika Maria 4
Accession 0001193805-24-000318
CIK 0001280776other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 9:50 PM ET
Size
8.4 KB
Accession
0001193805-24-000318
Insider Transaction Report
Form 4
IMMUNIC, INC.IMUX
Toernsen Monika Maria
Director
Transactions
- Disposition to Issuer
Stock Option
2024-03-04−30,000→ 0 totalExercise: $4.30Exp: 2031-07-18→ Common Stock (30,000 underlying) - Award
Stock Option
2024-03-04+30,000→ 30,000 totalExercise: $1.72Exp: 2031-07-18→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the "Eligible Options") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date.
Documents
Issuer
IMMUNIC, INC.
CIK 0001280776
Entity typeother
Related Parties
1- filerCIK 0001873385
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 9:50 PM ET
- Size
- 8.4 KB